Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|November 19, 2016
Somatic overgrowth disorders of the PI3K/AKT/mTOR pathway & therapeutic strategiesKim M Keppler-Noreuil, Victoria E R Parker, Thomas N Darling, et al.
American Journal of Respiratory Cell and Molecular Biology|February 7, 2018
The Lymphangioleiomyomatosis Lung Cell and Its Human Cell ModelsWendy K Steagall, Gustavo Pacheco-Rodriguez, Thomas N Darling, et al.
Journal of the American Academy of Dermatology|May 14, 2010
Acral lesions in tuberous sclerosis complex: insights into pathogenesisCapt Shelley L Aldrich, Chien-Hui Hong, Leslie Groves, et al.
Annals of Internal Medicine|June 22, 2011
Recognition of tuberous sclerosis in adult women: delayed presentation with life-threatening consequencesDiane Seibert, Chien-Hui Hong, Fumiko Takeuchi, et al.
The Journal of Clinical Investigation|December 6, 2016
Tuberous sclerosis complex inactivation disrupts melanogenesis via mTORC1 activationJuxiang Cao, Magdalena E Tyburczy, Joel Moss, et al.
Histopathology|April 21, 2021
Histopathological features of fibrous cephalic plaques in tuberous sclerosis complexAlison M Treichel, Deeti J Pithadia, Chyi-Chia R Lee, et al.
Journal of the American Academy of Dermatology|December 21, 2017
Fibrous cephalic plaques in tuberous sclerosis complexOyetewa Oyerinde, Danielle Buccine, Alison Treichel, et al.
The Journal of Experimental Medicine|September 1, 2005
MCP-1 overexpressed in tuberous sclerosis lesions acts as a paracrine factor for tumor developmentShaowei Li, Fumiko Takeuchi, Ji-an Wang, et al.
Journal of the American Academy of Dermatology|September 15, 2015
Improvement of tuberous sclerosis complex (TSC) skin tumors during long-term treatment with oral sirolimusNeera Nathan, Ji-an Wang, Shaowei Li, et al.
Pageof 7